Pauls Matthew
Director at PTHS; Director at SOLENO THERAPEUTICS INC; Director at SVRA
- Sold, on record
- $1M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 2, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- PTHSPelthos Therapeutics Inc.Director
- SOLENO THERAPEUTICS INCDirector
- SVRASavara IncDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SVRA138,702 shares
- SOLENO THERAPEUTICS INC5,937 shares
- PTHS1,572 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice SVRANoticeDec 28, 2023 2023
Filed to sell 84,000 shares ($398k)
Pauls Matthew, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SVRANo planDec 28, 2023 same day
Sold 84,000 shares at $4.71 ($396k)
Pauls Matthew, CHIEF EXECUTIVE OFFICER
No 10b5-1 planSold 6.1% of holdings ($6.5M position)1.3M shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice SVRANoticeDec 16, 2024 +354 days
Filed to sell 54,702 shares ($181k)
Pauls Matthew, Director
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale SVRANo planDec 16, 2024 same day
Sold 54,702 shares at $3.31 ($181k)
Pauls Matthew, CHIEF EXECUTIVE OFFICER
No 10b5-1 planSold 3.4% of holdings ($5.3M position)1.5M shares leftFollows a Form 144Filing
- 5 Form 4 sale SOLENO THERAPEUTICS INCUnusualMar 28, 2025 +102 days
Sold 5,937 shares at $71.55 ($425k)
Pauls Matthew, Director
No 10b5-1 planSold 47.7% of holdings ($890k position)6,500 shares leftFirst sale on recordFiling
- 6 Form 4 sale PTHSRoutineApr 2, 2026 +370 days
Sold 786 shares at $20.92 ($16k)
Pauls Matthew, Director
10b5-1 planSold 4.9% of holdings ($333k position)15,150 shares leftFirst sale on recordFiling
- 7 Form 4 sale PTHSRoutineJul 2, 2026 +91 days
Sold 786 shares at $26.16 ($21k)
Pauls Matthew, Director
10b5-1 planSold 5.2% of holdings ($396k position)14,364 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Jul 7, 2026 | PTHS | Director | Form 4 sale | 786 | $21k | 5.2% | Routine | SEC |
| Apr 2, 2026 | Apr 6, 2026 | PTHS | Director | Form 4 sale | 786 | $16k | 4.9% | Routine | SEC |
| Mar 28, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | Director | Form 4 sale | 5,937 | $425k | 47.7% | Unusual | SEC |
| Dec 16, 2024 | Dec 16, 2024 | SVRA | CHIEF EXECUTIVE OFFICER | Form 4 sale | 54,702 | $181k | 3.4% | No plan | SEC |
| Dec 16, 2024 | Dec 16, 2024 | SVRA | Director | Form 144 notice | 54,702 | $181k | Notice | SEC | |
| Dec 28, 2023 | Dec 29, 2023 | SVRA | CHIEF EXECUTIVE OFFICER | Form 4 sale | 84,000 | $396k | 6.1% | No plan | SEC |
| Dec 28, 2023 | Dec 28, 2023 | SVRA | Officer, Director | Form 144 notice | 84,000 | $398k | Notice | SEC |